louisiana semaglutide ban Novo Nordisk, Eli Lilly Sending Cease-and-Desist Letters Over Compounded US states drop Medicaid coverage

If a drug demonstrates the possibility of causing mental or physical dependence and abuse, it is labeled as a controlled substance

Its side effects can include digestive issues

The insulin sensitivity advantage for tirzepatide is larger than weight loss alone explains (Diabetes, Obesity and Metabolism, 2025), which suggests the GIP component does real metabolic work beyond appetite suppression

Additionally, oral semaglutide for weight loss in non diabetics is an approved use, so you don't need a diabetes diagnosis

IBS-C: The Risk of Increased Constipation Conversely, for those with IBS-C (constipation-predominant), the introduction of a medication that slows motility requires careful consideration